1. STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas
   Nadège Dubois et al, 2022, International Journal of Oncology CrossRef
2. MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
   Mengyang Chang et al, 2022, Acta Materia Medica CrossRef
3. Nanoparticle-facilitated delivery of BAFF-R siRNA for B cell intervention and rheumatoid arthritis therapy
   Huihui Wu et al, 2020, International Immunopharmacology CrossRef